Anne Kasmar | Senior Vice President, Global Therapeutic Head, Infectious Disease and Vaccines
Parexel
Anne has more than 15 years of experience in clinical and translational research. Before joining Parexel, she was lead medical director, overseeing teams that researched new therapies for graft-versus-host disease and novel antibiotics. She also served as program officer at the Bill and Melinda Gates Foundation, building and managing the investment portfolio in next-generation tuberculosis vaccines. At Parexel, she heads the infectious disease franchise.
Appearances:
Main Congress Day 2 - 23rd April @ 12:40
Launching & leading successful vaccine studies: the essential role of Parexel’s site alliance network
This presentation will highlight how our strong site alliance network accelerates start-up, and streamlines conduct of vaccine trials, leading to fast and efficient study execution.
- Parexel's Site Alliance Network includes over 350 alliance institutions and 21,000+ site investigators across 27 countries
- Key benefits for sites include assignment of a dedicated alliance manager and contract lead, as well as one-time negotiation of a master service agreement
- Key benefits for sponsors include active, early engagement that optimizes participant recruitment and retention while ensuring patient-centered study design
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events